Filed: 11/13/2023ACC: 0000904454-23-000604
📋 What this filing means
FINEPOINT CAPITAL LP filed this quarterly 13F‑HR report disclosing 30 equity positions with a total reported market value of $200.80M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
30
Positions
$200.80M
Total AUM (reported)
16.62M
Total Shares
Allocation by class
COM$117.02M58.3%
CLASS A ORD$18.89M9.4%
SHS$16.85M8.4%
SPON ADR$15.85M7.9%
COM NEW$15.56M7.7%
SPONSORED ADR$15.34M7.6%
*W EXP 02/02/202$333.6K0.2%
Portfolio Concentration
Top 3$54.62M27.2%
4–10$97.75M48.7%
11–25$48.37M24.1%
Rest$65.3K0.0%
Top 3 weight
27.2%
Top 10 weight
75.9%
Voting Authority Distribution
Total shares with voting rights: 16.62M
Sole
Full voting authority
16.62M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole30
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings30
Rows:
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares331.42K
TypeSH
Market value$18.89M
9.41%
Sole
331.42K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares1.49M
TypeSH
Market value$18.11M
9.02%
Sole
1.49M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares145.36K
TypeSH
Market value$17.62M
8.78%
Sole
145.36K
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares349.30K
TypeSH
Market value$16.85M
8.39%
Sole
349.30K
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares458.66K
TypeSH
Market value$15.85M
7.89%
Sole
458.66K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares163.77K
TypeSH
Market value$15.34M
7.64%
Sole
163.77K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares556.93K
TypeSH
Market value$12.88M
6.41%
Sole
556.93K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares431.69K
TypeSH
Market value$12.72M
6.33%
Sole
431.69K
Shared
0.00
None
0.00
CEREVEL THERAPEUTICS HLDNG I
SOLEShares563.35K
TypeSH
Market value$12.30M
6.12%
Sole
563.35K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares427K
TypeSH
Market value$11.82M
5.89%
Sole
427K
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares556.55K
TypeSH
Market value$11.60M
5.78%
Sole
556.55K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares504.70K
TypeSH
Market value$9.91M
4.94%
Sole
504.70K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares895.82K
TypeSH
Market value$8.01M
3.99%
Sole
895.82K
Shared
0.00
None
0.00
MORPHIC HOLDING INC
SOLEShares325.36K
TypeSH
Market value$7.45M
3.71%
Sole
325.36K
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares870.87K
TypeSH
Market value$7.32M
3.65%
Sole
870.87K
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares961.25K
TypeSH
Market value$2.42M
1.21%
Sole
961.25K
Shared
0.00
None
0.00
CALIDI BIOTHERAPEUTICS INC
SOLEShares125K
TypeSH
Market value$415.6K
0.21%
Sole
125K
Shared
0.00
None
0.00
ARES ACQUISITION CORP
SOLEShares504.71K
TypeSH
Market value$333.6K
0.17%
Sole
504.71K
Shared
0.00
None
0.00
BRIDGETOWN HOLDINGS LTD
SOLEShares895K
TypeSH
Market value$304.3K
0.15%
Sole
895K
Shared
0.00
None
0.00
CHURCHILL CAPITAL CORP VII
SOLEShares548K
TypeSH
Market value$168.8K
0.08%
Sole
548K
Shared
0.00
None
0.00
CALIDI BIOTHERAPEUTICS INC
SOLEShares655.20K
TypeSH
Market value$144.1K
0.07%
Sole
655.20K
Shared
0.00
None
0.00
COMPASS DIGITAL ACQUISITION CORP
SOLEShares459.91K
TypeSH
Market value$101.3K
0.05%
Sole
459.91K
Shared
0.00
None
0.00
CHURCHILL CAPITAL CORP VI
SOLEShares540K
TypeSH
Market value$86.4K
0.04%
Sole
540K
Shared
0.00
None
0.00
ROSS ACQUISITION CORP II
SOLEShares439.67K
TypeSH
Market value$49.0K
0.02%
Sole
439.67K
Shared
0.00
None
0.00
CONCORD ACQUISITION CORP II
SOLEShares408.33K
TypeSH
Market value$42.6K
0.02%
Sole
408.33K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 331.42K | SH | $18.89M 9.41% | 331.42K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 1.49M | SH | $18.11M 9.02% | 1.49M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 145.36K | SH | $17.62M 8.78% | 145.36K | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 349.30K | SH | $16.85M 8.39% | 349.30K | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 458.66K | SH | $15.85M 7.89% | 458.66K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 163.77K | SH | $15.34M 7.64% | 163.77K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 556.93K | SH | $12.88M 6.41% | 556.93K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 431.69K | SH | $12.72M 6.33% | 431.69K | 0.00 | 0.00 |
CEREVEL THERAPEUTICS HLDNG ISOLE | COM | 563.35K | SH | $12.30M 6.12% | 563.35K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 427K | SH | $11.82M 5.89% | 427K | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 556.55K | SH | $11.60M 5.78% | 556.55K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 504.70K | SH | $9.91M 4.94% | 504.70K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 895.82K | SH | $8.01M 3.99% | 895.82K | 0.00 | 0.00 |
MORPHIC HOLDING INCSOLE | COM | 325.36K | SH | $7.45M 3.71% | 325.36K | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 870.87K | SH | $7.32M 3.65% | 870.87K | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 961.25K | SH | $2.42M 1.21% | 961.25K | 0.00 | 0.00 |
CALIDI BIOTHERAPEUTICS INCSOLE | COM NEW | 125K | SH | $415.6K 0.21% | 125K | 0.00 | 0.00 |
ARES ACQUISITION CORPSOLE | *W EXP 02/02/202 | 504.71K | SH | $333.6K 0.17% | 504.71K | 0.00 | 0.00 |
BRIDGETOWN HOLDINGS LTDSOLE | *W EXP 09/30/202 | 895K | SH | $304.3K 0.15% | 895K | 0.00 | 0.00 |
CHURCHILL CAPITAL CORP VIISOLE | *W EXP 02/29/202 | 548K | SH | $168.8K 0.08% | 548K | 0.00 | 0.00 |
CALIDI BIOTHERAPEUTICS INCSOLE | *W EXP 03/14/202 | 655.20K | SH | $144.1K 0.07% | 655.20K | 0.00 | 0.00 |
COMPASS DIGITAL ACQUISITION CORPSOLE | *W EXP 09/29/202 | 459.91K | SH | $101.3K 0.05% | 459.91K | 0.00 | 0.00 |
CHURCHILL CAPITAL CORP VISOLE | *W EXP 02/17/202 | 540K | SH | $86.4K 0.04% | 540K | 0.00 | 0.00 |
ROSS ACQUISITION CORP IISOLE | *W EXP 02/01/202 | 439.67K | SH | $49.0K 0.02% | 439.67K | 0.00 | 0.00 |
CONCORD ACQUISITION CORP IISOLE | *W EXP 99/99/999 | 408.33K | SH | $42.6K 0.02% | 408.33K | 0.00 | 0.00 |
Page 1 of 2